Risk Variants and Polygenic Architecture of Disruptive Behavior Disorders in the Context of Attention-deficit/hyperactivity Disorder
Overview
Authors
Affiliations
Attention-Deficit/Hyperactivity Disorder (ADHD) is a childhood psychiatric disorder often comorbid with disruptive behavior disorders (DBDs). Here, we report a GWAS meta-analysis of ADHD comorbid with DBDs (ADHD + DBDs) including 3802 cases and 31,305 controls. We identify three genome-wide significant loci on chromosomes 1, 7, and 11. A meta-analysis including a Chinese cohort supports that the locus on chromosome 11 is a strong risk locus for ADHD + DBDs across European and Chinese ancestries (rs7118422, P = 3.15×10, OR = 1.17). We find a higher SNP heritability for ADHD + DBDs (h = 0.34) when compared to ADHD without DBDs (h = 0.20), high genetic correlations between ADHD + DBDs and aggressive (r = 0.81) and anti-social behaviors (r = 0.82), and an increased burden (polygenic score) of variants associated with ADHD and aggression in ADHD + DBDs compared to ADHD without DBDs. Our results suggest an increased load of common risk variants in ADHD + DBDs compared to ADHD without DBDs, which in part can be explained by variants associated with aggressive behavior.
Bouliane M, Boivin M, Kretschmer T, Lafreniere B, Paquin S, Tremblay R Eur Child Adolesc Psychiatry. 2025; .
PMID: 39907790 DOI: 10.1007/s00787-025-02654-4.
Editorial: Advancements and challenges in developmental psychopathology and mental health.
Melchior M Front Child Adolesc Psychiatry. 2025; 2():1271736.
PMID: 39816855 PMC: 11731978. DOI: 10.3389/frcha.2023.1271736.
Rare Association of Congenital Atrichia with Central Nervous System: A Report of Three Cases.
Swamynathan S, Srinivas S, Khan H Int J Trichology. 2024; 15(6):248-250.
PMID: 39600419 PMC: 11588192. DOI: 10.4103/ijt.ijt_58_21.
Genetics of child aggression, a systematic review.
Koyama E, Kant T, Takata A, Kennedy J, Zai C Transl Psychiatry. 2024; 14(1):252.
PMID: 38862490 PMC: 11167064. DOI: 10.1038/s41398-024-02870-7.
Generalized genetic liability to substance use disorders.
Miller A, Bogdan R, Agrawal A, Hatoum A J Clin Invest. 2024; 134(11).
PMID: 38828723 PMC: 11142744. DOI: 10.1172/JCI172881.